Preview | Issue Date | Title | Author(s) |
| 2006 | 99mTc-Evans blue dye for mapping contiguous lymph node sequences and discriminating the sentinel lymph node in an ovine model | Tsopelas, C.; Bevington, E.; Kollias, J.; Shibli, S.; Farshid, G.; Coventry, B.; Chatterton, B. |
| 2017 | Assessing impact of organised breast screening across small residential areas-development and internal validation of a prediction model | Buckley, E.; Farshid, G.; Gill, G.; Kollias, J.; Koczwara, B.; Karapetis, C.; Adams, J.; Joshi, R.; Keefe, D.; Niyonsenga, T.; Powell, K.; Fusco, K.; Eckert, M.; Beckmann, K.; Roder, D. |
| 2008 | Assessment of 1183 screen-detected, category 3B, circumscribed masses by cytology and core biopsy with long-term follow up data | Farshid, G.; Downey, P.; Gill, P.; Pieterse, S. |
| 2004 | Assessment of 142 stellate lesions with imaging features suggestive of radial scar discovered during population-based screening for breast cancer | Farshid, G.; Rush, G. |
| 2005 | Combined use of imaging and cytologic grading schemes for screen-detected breast abnormalities improves overall diagnostic accuracy | Farshid, G.; Downey, P. |
| 2006 | Core imprint cytology of screen-detected breast lesions is predictive of the histologic results | Farshid, G.; Pieterse, S. |
| 2007 | Feasibility study on the MammoSite in early-stage breast cancer: initial experience | Borgas, M.; Yeoh, E.; Bochner, M.; Butters, J.; Van Doorn, T.; Farshid, G.; Kollias, J.; Kotasek, D.; Gill, P.; Lim, A.; Olver, I.; Parnis, F.; Rush, G. |
| 2012 | Gastric HER2 Testing Study (GaTHER): An Evaluation of Gastric/Gastroesophageal Junction Cancer Testing Accuracy in Australia | Fox, S.; Kumarasinghe, M.; Armes, J.; Bilous, M.; Cummings, M.; Farshid, G.; Fitzpatrick, N.; Francis, G.; McCloud, P.; Raymond, W.; Morey, A. |
| 2006 | Histopathological features of breast cancer in carriers of ATM gene variants | Balleine, R.; Murali, R.; Bilous, A.; Farshid, G.; Waring, P.; Provan, P.; Byth, K.; Thorne, H.; Kirk, J. |
| 2006 | Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing | Farshid, G.; Balleine, R.; Cummings, M.; Waring, P. |
| 2005 | Mucocele-like lesions of the breast: a benign cause for indeterminate or suspicious mammographic microcalcifications | Farshid, G.; Pieterse, S.; King, J.; Robinson, J. |
| 2008 | Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mamography screening in Australia | Roder, D.; Houssami, N.; Farshid, G.; Gill, P.; Luke, C.; Downey, P.; Beckmann, K.; Iosifidis, P.; Grieve, L.; Williamson, L. |
| 2003 | Predicting the HER2 status of breast cancer from basic histopathology data: an analysis of 1500 breast cancers as part of the HER2000 International Study | Bilous, M.; Ades, C.; Ames, J.; Bishop, J.; Brown, R.; Cooke, B.; Cummings, M.; Farshid, G.; Field, A.; Morey, A.; McKenzie, P.; Raymond, W.; Robbins, P.; Tan, L. |
| 1999 | Reliability of sentinel node status in predicting axillary lymph node involvement in breast cancer | Kollias, J.; Gill, P.; Chatterton, B.; Hall, V.; Bochner, M.; Coventry, B.; Farshid, G. |
| 2001 | Spindle cell ductal carcinoma in situ - An unusual variant of ductal intra-epithelial neoplasia that simulates ductal hyperplasia or a myoepithelial proliferation | Farshid, G.; Moinfar, F.; Meredith, D.; Peiterse, S.; Tavassoli, F. |
| 2006 | The tissue distribution of Evans blue dye in a sheep model of sentinel node biopsy | Green, M.; Farshid, G.; Kollias, J.; Chatterton, B.; Tsopelas, C. |
| 2003 | The use of fine-needle aspiration cytology and core biopsy in the assessment of highly suspicious mammographic microcalcifications - Analysis of outcome for 182 lesions detected in the setting of a population-based breast cancer screening program | Farshid, G.; Rush, G. |